BlueChew is not designed for women and does not offer prescriptions to female patients. The service provides chewable tablets containing erectile dysfunction medications, which work by increasing blood flow to the penis. These drugs are FDA-approved only for men with erectile dysfunction, and BlueChew’s telehealth platform is built around that specific use case. Women looking for help with sexual health concerns need different options entirely.
Why BlueChew’s Medications Don’t Work the Same Way in Women
The active ingredients in BlueChew belong to a class of drugs that relax blood vessels and increase blood flow. In men, this targeted blood flow produces erections. In women, the biology of sexual arousal and desire involves a much more complex interplay of hormones, brain chemistry, and blood flow, so simply boosting circulation to the genitals doesn’t reliably translate into improved sexual function.
Women can technically take these medications. The Cleveland Clinic notes that the FDA has not approved them for use in women, and because research hasn’t proven clear benefits, most healthcare providers consider them a last resort rather than a first-line treatment. Some small studies have explored whether increased genital blood flow helps women with arousal difficulties, but results have been inconsistent and underwhelming compared to the strong, measurable effects seen in men.
Side Effects Women Should Know About
Even when taken off-label, these medications carry real risks. The most commonly reported side effects in women across studies include headache, flushing, nausea, nasal congestion, and visual disturbances. Women who have low blood pressure or take blood pressure medication face an additional danger: the drug can cause a further drop in blood pressure, leading to dizziness or fainting. Mixing it with alcohol worsens these side effects.
There’s also a serious interaction risk. Anyone taking nitrate medications (commonly prescribed for chest pain) should never combine them with this class of drug, as the combination can cause a dangerous and potentially life-threatening drop in blood pressure.
FDA-Approved Options That Actually Target Women’s Sexual Health
The reason women search for something like BlueChew is usually low sexual desire or difficulty with arousal. Two prescription medications have been specifically approved by the FDA for premenopausal women with persistently low sexual desire that causes personal distress.
The first is a daily oral tablet (flibanserin, sold as Addyi) that works entirely differently from erectile dysfunction drugs. Instead of affecting blood flow, it adjusts brain chemistry by boosting dopamine and norepinephrine while lowering serotonin. These are the neurotransmitters involved in motivation, pleasure, and mood. Because it works on brain pathways rather than plumbing, it takes several weeks of daily use before effects become noticeable. Alcohol must be avoided while taking it, as the combination can cause severe drops in blood pressure and loss of consciousness.
The second option (bremelanotide, sold as Vyleesi) is a self-administered injection given in the thigh or abdomen at least 45 minutes before anticipated sexual activity. It activates receptors in the brain involved in sexual desire. Unlike the daily tablet, it’s used only as needed, which appeals to some women. Nausea is the most common side effect, particularly after the first injection.
Both medications are available only by prescription and only for premenopausal women. Neither is available through BlueChew or similar telehealth platforms that focus exclusively on male erectile dysfunction.
What Women Can Actually Do
If you’re experiencing low desire, difficulty with arousal, or pain during sex, the underlying causes are often different from what drives erectile dysfunction in men. Hormonal shifts from birth control, postpartum changes, perimenopause, stress, relationship dynamics, and certain antidepressants all commonly affect women’s sexual function. A gynecologist or sexual medicine specialist can help identify whether the issue is hormonal, psychological, medication-related, or some combination.
For postmenopausal women specifically, vaginal dryness and tissue changes are extremely common and highly treatable with localized estrogen therapy or non-hormonal moisturizers. These concerns look nothing like erectile dysfunction and respond to completely different interventions. Trying to solve them with a BlueChew-style product would be ineffective and potentially risky.